SBN 0.00% 0.0¢ sun biomedical limited

vulnerable, page-8

  1. 988 Posts.
    I think competitors will have no choice in the near term. Our product is now protected by a patent that has been tested in the US Courts. Avitar is no small fish.

    Our competetitors cannot get 1:1 Saliva:Drug (THC) through their collection devices, which hinders their ability to market their respective products to achieve SAMHSA levels for THC. These levels will need to be achieved in the US Workplace.

    Saliva drug testing will be a massive industry in the near term, appears to gain traction each day.

    Watch this space - "The only one that works..."

    Oraline 8 - mindblowing, membrane that tests 8 drugs in one single application - another advantage over our competitors.

 
watchlist Created with Sketch. Add SBN (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.